DC

Doug Cubbin

Oncosil Medical Limited | Non-Executive Director
Mr Cubbin is an experienced biopharmaceutical executive with over 30 years' experience in senior executive, CFO, Director and Chair roles, across industries. During his tenure as Group Chief Financial Officer at Telix Pharmaceuticals Limited, a global biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals, he was a member of the team which completed the IPO, raised $270 million in capital and grew the business to a multi-billion dollar market capitalisation. Mr Cubbin has also served as Chairman of various boards, including Australian Nuclear Science and Technology Organisation (ANSTO) Nuclear Medicine. He is member of Risk Committee.

Company and Role

Company
Title
Tenure
Since
OSL
Oncosil Medical Limited
  • Non-Executive Director
1yrs, 6mthAug 2023

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
OSL
Oncosil Medical Limited
13/12/2415,000,00025,000,00037,500,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
OSL
Oncosil Medical Limited
13/12/24
Issued
10,000,000$0.010$100,000Placement
OSL
Oncosil Medical Limited
13/12/24
Issued
10,000,000$0.007$70,000Placement
OSL
Oncosil Medical Limited
20/05/24
Issued
22,500,000$0.005$112,500Placement
OSL
Oncosil Medical Limited
20/05/24
Issued
15,000,000$0.005$75,000Placement
OSL
Oncosil Medical Limited
19/12/23
Issued
5,000,000$0.007$35,000Issue of options